Nestle India, Zydus Wellness slide as regulator probes claims on children's products
22/10/2026 05:07
BUZZ-Nestle India, Zydus Wellness slide as regulator probes claims on children's products ** Nestle India NEST.NS falls 2.7%, while Zydus Wellness ZYDS.NS declines 2% after India's food regulator issues notices over promotional claims for infant and children's products
** The regulator asks NEST to provide evidence supporting digestive and immune-health claims for its Lactogen Pro 1 Powder and NAN Excella Pro Stage 1 infant formula products
** Zydus Wellness is asked to scientifically justify claims for Complan, including the tagline "grow taller, faster. clinically proven 2X growth"
** NEST says the latest communication reiterates concerns raised on Sept 18 regarding product labels and adds it has already submitted a detailed response
** ZYDS did not respond to Reuters request for comment
(Reporting by Kashish Tandon in Bengaluru)
Recent news on Zydus Wellness
See all newsBrief: Zydus Wellness Issues Clarification On Recent News Item Dated October 22, 2026
India's Zydus Wellness heads for steepest weekly drop since Feb amid regulatory scrutiny
India Stocks: Indian shares slip as high oil prices fuel inflation worries
Nestle India, Zydus Wellness slide as regulator probes claims on children's products
Nestle, Zydus, Abbott face India scrutiny over claims on children's products (updated)